Skip to content
Open access

Mouse genetic mosaic model for basal-like breast cancer reveals disruption of basal-myoepithelial architecture at premalignancy

Jul 2026 · Research Square · 0 citations · 54 references
Medicine

TL;DR

This work identifies disruption of the basal cell layer as an early hallmark of premalignant progression, supporting a chronology in which architectural remodeling of the mammary epithelium precedes malignant progression.

Abstract

In early cancer evolution, mutant cells must escape tissue-architectural constraints before progressing to malignancy. In the case of invasive breast cancers, loss of integrity of the wildtype basal-myoepithelial layer that wraps around premalignant luminal cells precedes the formation of an invasive tumor mass. The spatiotemporal details of these early events have remained elusive. Here, we used the Mosaic Analysis with Double Markers (MADM) mouse model of basal-like breast cancer to generate rare, GFP-labeled, premalignant luminal cells within an otherwise colorless, normal mouse, and pinpointed hyperalveolarization from the ducts as a key phase of progression, several months before malignant transformation. Using a whole-mount tissue clearing-staining-imaging workflow to examine the colorless basal-myoepithelial cell layer that surrounds GFP-labeled premalignant luminal cells, we observed a gradual disruption of the basal-myoepithelial layer during the hyperalveolarization phase. Increased cell size, altered cell morphology, and elevated proliferation of mutant cells occurred independently of basal disruption. In contrast, expression of the basal marker Keratin 14 in premalignant luminal cells, a feature that contributes to the “basal-like” nomenclature of this cancer, was strongly associated with basal disruption, suggesting that basal cell-mediated containment may suppress a critical transition in premalignant cell state. This work identifies disruption of the basal cell layer as an early hallmark of premalignant progression, supporting a chronology in which architectural remodeling of the mammary epithelium precedes malignant progression.

Read PDF

Similar papers

Aug 2026

Germline BRCA1 Mutation Deregulates Irradiation–Induced Cell Cycle Checkpoints in Human Mammary Luminal Progenitors

A lineage-resolved monolayer culture system is established that enables propagation of primary human mammary epithelial populations while preserving lineage identity across passages and provides a functional framework for determining critical events in the expansion of genomically altered mammary epithelial cells in th...

Abhijith Kuttanamkuzhi, Bowen Zhang, Kelvin Yeung et al. · 0 citations
Open access Aug 2026

Stroma-Dominant Colorectal Cancer Harbors CAF-Rich Spatial Architecture and EMT-Associated Cancer Cell Plasticity Detectable After Dissemination

Stroma-dominant CRC is characterized as a spatially organized ecosystem in which a CAF-rich compartment is associated with stress-adapted cancer cell programs, and its poor prognosis may involve not only stromal abundance but also a morphology-associated cancer cell state detectable after dissemination.

S. Kitagawa, N. Mimura, Hironobu Kambara et al. · 0 citations
Open access Aug 2026

In Luminal A breast cancer, bulk FOXC1 reports the tumour vasculature, while a proliferation-independent basal-lineage axis marks the tumour cells

FOXC1 is widely interpreted as a tumour-cell driver of basal identity and immune phenotype in breast cancer, including within the Luminal A (LumA) subtype, where its bulk expression tracks basal-like features and immune infiltration. Because LumA tumours are compositionally heterogeneous, whether this reflects malignan...

Daniel E. Yehoshua, J. C. Bingham · 0 citations
Open access Sep 2026

Single-Cell Analysis Guides Organoid CRISPR Screening to Reveal NF1 as a Gatekeeper of Cervical Squamous Malignant Transformation.

These findings establish NF1 as a critical constraint on HPV-associated epithelial evolution and provide a time-compressed organoid model of cervical carcinogenesis, offering proof-of-concept for therapeutic RAS pathway interception via NF1 restoration.

Bai Hu, Liang Chen, Ren-Jie Wang et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.